2025-08-26

INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025

2025-08-18

VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE I CLINICAL TRIAL OF IMC-003/IMM72

2025-08-12

DATE OF BOARD MEETING

2025-08-05

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2025

2025-07-30

VOLUNTARY ANNOUNCEMENT - MILESTONE PAYMENT RECEIVED UNDER THE LICENSE AND COLLABORATION AGREEMENT WITH AXION BIO

2025-07-11

VOLUNTARY ANNOUNCEMENT - UNUSUAL PRICE MOVEMENTS

2025-07-07

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2025

2025-07-02

VOLUNTARY ANNOUNCEMENT - CLEARANCE OF IND APPLICATION FOR IMM2510/AXN-2510 BY THE U.S. FDA

2025-06-30

Terms of Reference of the Nomination Committee

2025-06-30

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

2025-06-30

CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE

2025-06-23

VOLUNTARY ANNOUNCEMENT - APPROVAL BY NMPA FOR THE CLINICAL TRIAL OF IMC-003/IMM72

2025-06-16

DISCLOSEABLE TRANSACTIONS - REDEMPTION AND SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS

2025-06-16

DISCLOSEABLE TRANSACTIONS - REDEMPTION AND SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS

2025-06-09

VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF MEDICAL OFFICER

2025-06-05

(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2025

2025-06-05

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2025

2025-05-28

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

2025-05-28

I. POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 28, 2025; II. APPOINTMENT OF DIRECTOR

2025-05-27

SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTIONS IN RELATION TO SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS